Indivior competitive analysis

Explore Indivior's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jul 1, 2020Buprenorphine Dosing Regimens1
Jun 19, 2019Sublingual And Buccal Film Compositions1
Jan 10, 2018Injectable Flowable Composition Comprising Buprenorphine1
Jan 6, 2016Sustained Delivery Formulations Of Risperidone Compounds1

Latest PTAB cases involving Indivior

Discover the latest PTAB cases involving Indivior, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 9, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Indivior

IPR2019-00328Nov 13, 2018DR REDDYS LABORATORIESINDIVIOR UKInstitution Denied
IPR2019-00329Nov 13, 2018DR REDDYS LABORATORIESINDIVIOR UKFinal Written Decision
IPR2018-00795Mar 16, 2018INDIVIORRHODES PHARMACEUTICALS LPInstitution Denied
IPR2016-01113May 31, 2016DR REDDYS LABORATORIESINDIVIOR UKInstitution Denied
IPR2016-00280Dec 3, 2015TEVA PHARMACEUTICALSINDIVIOR UKInstitution Denied

Peer Comparison New

IP litigation analysis comparing Indivior with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INDIVIOR UK - 4 - 4
DR REDDYS LABORATORIES11727 -
ELKINGTON AND FIFE104 - - -
LECOMTE & PARTNERS2 - - -